Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1
Mirjam E. Meltzer(Leiden University Medical Center), Frits R. Rosendaal(Leiden University Medical Center), Ton Lisman(University Medical Center Groningen), Joost C. M. Meijers(Amsterdam UMC Location University of Amsterdam), Philip G. de Groot(Synapse (Netherlands)), Saskia le Cessie(Leiden University Medical Center), Carine J.M. Doggen(Rijnstate Hospital)
Cited by 363
Related Papers
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
|Journal of Thrombosis and Haemostasis|2006|7.1k
Incidence and mortality of venous thrombosis: a population‐based study
|Journal of Thrombosis and Haemostasis|2007|1.4k
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study
|The Lancet|2011|1.3k
Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
|The Lancet|1994|1.1k
Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
|New England Journal of Medicine|1996|1.1k